Reducing unnecessary blood transfusions | RNA to treat prostate cancer | $5M for Black medical schools
November 17, 2021
ROCHESTER, MN—Eliminating unnecessary allogenic blood transfusions (when a donor and a recipient are not the same person) is critical when donor blood is in short supply. A Mayo Clinic study indicates that hospitals can reduce unnecessary blood transfusions and costs by implementing patient blood management programs. The data analytics study saw a risk reduction of 6% for receiving any transfusion during hospitalization.
ST. LOUIS, MO—A new study from Washington University School of Medicine in St. Louis indicates that RNA could be a new strategy to treat prostate cancer that has developed resistance to hormonal therapies. The researchers identified an RNA molecule, which they dubbed NXTAR, that suppresses prostate tumors.
CLEVELAND, OH—University Hospitals is deploying Interactions’ AI-powered virtual assistant to schedule appointments. The tool will seek to alleviate long wait times over the phone or accidental misdirections. It will also allow patients to update their profiles; schedule, reschedule or cancel appointments; or obtain appointment details without needing an agent.